"
Team:UIUC Illinois/Human Practices/Ethics
From 2013.igem.org
(Difference between revisions)
Ashleysmoy (Talk | contribs) |
|||
| Line 9: | Line 9: | ||
<script> | <script> | ||
$(function() { | $(function() { | ||
| - | $( "#accordion" ).accordion({ active: | + | $( "#accordion" ).accordion({ active: 4 }); |
$( "#accordion" ).accordion({ collapsible: true }); | $( "#accordion" ).accordion({ collapsible: true }); | ||
}); | }); | ||
Revision as of 23:20, 27 September 2013
Contact Us
That said, the scope of our project is more focused than the broad category of "GMOs." Our probiotic is simply that: a probiotic contained within the human body of those who ingest it. Luckily, this means that our organism cannot impact local ecosystems or other living creatures; this makes the debate much easier than discussions over GM crops.
With appropriate time and resources, a fully realized Cardiobiotics cell would contain no antibiotic resistances. Since the entirety of changes to its genome are contained in a single replicating cell, it is significantly easier to analyze any potential side-effects of integrating our parts into the genome of the cell when compared to multicellular organisms. For this reason we feel that the nature of a modified Nissle 1917 could be fully analyzed and confirmed as truly safe.
Because our Cardiobiotics are nothing more than new additions to the gut flora, it is not necessary to worry about elimination from the human body. Cardiobiotics cell are optimized for growth within the human body; once outside of it, their chances of survival are quite weak. Transgenic gene transfer is not a concern, either! In the rare case that such an event occurs in the digestive system, it is unlikely to harm the body whatsoever; in extreme or concerning cases, the bacteria of the gut flora may be eliminated directly through the use of antibiotics.
It is our hope that as more and more useful technologies made possible by genetic engineering enter the public sphere, that more early start-up companies will be accepted by the public for their valuable skills and products.
Home
About
Project
Achievements
Human Practices
Safety
Genetic Engineering, Probiotics, and Ethics: the Bioengineer's Dilemma
That said, the scope of our project is more focused than the broad category of "GMOs." Our probiotic is simply that: a probiotic contained within the human body of those who ingest it. Luckily, this means that our organism cannot impact local ecosystems or other living creatures; this makes the debate much easier than discussions over GM crops.
With appropriate time and resources, a fully realized Cardiobiotics cell would contain no antibiotic resistances. Since the entirety of changes to its genome are contained in a single replicating cell, it is significantly easier to analyze any potential side-effects of integrating our parts into the genome of the cell when compared to multicellular organisms. For this reason we feel that the nature of a modified Nissle 1917 could be fully analyzed and confirmed as truly safe.
Because our Cardiobiotics are nothing more than new additions to the gut flora, it is not necessary to worry about elimination from the human body. Cardiobiotics cell are optimized for growth within the human body; once outside of it, their chances of survival are quite weak. Transgenic gene transfer is not a concern, either! In the rare case that such an event occurs in the digestive system, it is unlikely to harm the body whatsoever; in extreme or concerning cases, the bacteria of the gut flora may be eliminated directly through the use of antibiotics.
It is our hope that as more and more useful technologies made possible by genetic engineering enter the public sphere, that more early start-up companies will be accepted by the public for their valuable skills and products.
